Search Prime Grants

R01HL159170

Project Grant

Overview

Grant Description
Using wearable technology to assess recovery and detect post-operative complications following cardiothoracic surgery - project summary.

Every year, more than 500,000 patients undergo operations for heart and lung disease. After surgery, patients often experience pain, fatigue, and disturbed sleep that can persist for weeks to months.

In addition, up to 32% of patients develop postoperative complications, which often occur after discharge from the hospital and may lead to readmission. Complications are costly and can be deadly; they are associated with a 200-300% increase in healthcare costs and a 6-fold increase in 90-day postoperative mortality.

Currently, after surgery, when a patient is discharged from the hospital, the patient and their family members are responsible for monitoring the patient’s health status. Patients are usually not seen by a doctor for 2-4 weeks after discharge.

Attempts to improve postoperative monitoring include home health visits and telemedicine approaches. However, these methods have been shown to be ineffective, costly, and allow for only vague and intermittent assessments of recovery. They do not detect complications until they are at a more severe stage.

As such, accurate, easy-to-implement and inexpensive methods to assess postoperative recovery and to detect complications at their earliest stage—before symptom onset—are urgently needed.

We previously showed that machine learning analysis of biometrics collected by wearables could detect Lyme disease and COVID-19. We then, in a pilot study, applied our algorithm, previously developed to identify COVID-19, to patients undergoing thoracic surgery and showed that this algorithm could detect 89% of complications a median of 3 days before symptom onset.

When we evaluated the postoperative recovery of cardiothoracic patients, we showed that machine learning analysis of biometrics could classify patients into distinct recovery groups. Thus, wearables and machine learning algorithms could lead to a highly accurate and accessible method to predict complications early and improve assessments of recovery.

Our overall objective is to optimize and validate our machine learning algorithm—previously developed for the early detection of COVID-19—for the detection of postoperative complications prior to symptom onset and to use machine learning analysis to predict the quality of a patient’s recovery using pre- and intraoperative data.

Our project aims to first use wearables to collect high-resolution physiologic data of cardiothoracic surgical patients. We will then extend our previously developed algorithm for early detection of postoperative complications and develop an algorithm to predict the quality of a patient’s postoperative recovery.

The proposed project will develop an innovative method to detect postoperative complications prior to symptom onset and predict the quality of a patient’s postoperative recovery using pre- and intraoperative data. Importantly, our proposed method could be scaled to not only improve outcomes for cardiothoracic surgical patients, but for patients undergoing other types of surgery.

The results of this study will enable a future randomized trial that evaluates whether real-time postoperative monitoring with machine learning algorithms and wearables can lead to 1) earlier detection of complications, 2) earlier outpatient interventions that improve recovery and/or reduce severity of complications, and 3) decreases in unplanned hospital readmissions.
Funding Goals
NOT APPLICABLE
Place of Performance
Boston, Massachusetts 021142621 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 368% from $748,852 to $3,502,912.
The General Hospital Corporation was awarded Early Detection of Postoperative Complications with Wearable Technology Project Grant R01HL159170 worth $3,502,912 from National Heart Lung and Blood Institute in July 2022 with work to be completed primarily in Boston Massachusetts United States. The grant has a duration of 5 years and was awarded through assistance program 93.837 Cardiovascular Diseases Research. The Project Grant was awarded through grant opportunity NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).

Status
(Ongoing)

Last Modified 7/6/26

Period of Performance
7/1/22
Start Date
6/30/27
End Date
80.0% Complete

Funding Split
$3.5M
Federal Obligation
$0.0
Non-Federal Obligation
$3.5M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to R01HL159170

Subgrant Awards

Disclosed subgrants for R01HL159170

Transaction History

Modifications to R01HL159170

Additional Detail

Award ID FAIN
R01HL159170
SAI Number
R01HL159170-2399090907
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Funding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Awardee UEI
FLJ7DQKLL226
Awardee CAGE
0ULU5
Performance District
MA-08
Senators
Edward Markey
Elizabeth Warren

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Heart, Lung, and Blood Institute, National Institutes of Health, Health and Human Services (075-0872) Health research and training Grants, subsidies, and contributions (41.0) $1,480,254 100%
Modified: 7/6/26